A Study to Evaluate the Long Term Safety and Effectiveness of Novantrone Therapy Followed by Copaxone Treatment for Multiple Sclerosis
Clinical trial NCT00203086 · COMPLETED
Trial details
- NCT number
- NCT00203086
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2005-10-01
- Primary completion
- 2009-10-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.